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SUMMARY
Hematopoietic differentiation critically depends on
combinations of transcriptional regulators controlling
the development of individual lineages. Here, we re-
port the genome-wide binding sites for the five key
hematopoietic transcription factors—GATA1,GATA2,
RUNX1, FLI1, and TAL1/SCL—in primary human
megakaryocytes. Statistical analysis of the 17,263
regions bound by at least one factor demonstrated
that simultaneous binding by all five factors was the
most enrichedpattern andoftenoccurrednear known
hematopoietic regulators. Eight genes not previously
appreciated to function in hematopoiesis that were
bound by all five factors were shown to be essential
for thrombocyte and/or erythroid development in
zebrafish. Moreover, one of these genes encoding
the PDZK1IP1 protein shared transcriptional en-
hancer elements with the blood stem cell regulator
TAL1/SCL. Multifactor ChIP-Seq analysis in primary
human cells coupled with a high-throughput in vivo
perturbation screen therefore offers a powerful
strategy to identify essential regulators of complex
mammalian differentiation processes.
INTRODUCTION
Complex gene-regulatory networks control all metazoan devel-
opment (Davidson, 2001). Transcription factors (TFs) and the
cis-regulatory sequences to which they bind form the building
blocks of these gene-regulatory networks. Connectivity in these
networks has historically been determined using individual gene-
based assays or inferred from expression profiling. However,
gene by gene characterization of regulatory elements is slow
and inference of regulatory relationships based on variations in
gene expression alone cannot readily differentiate between
direct and indirect interactions. New genome-wide technologies
permit potentially rapid access to all regions bound by a given
factor. However, binding of a factor does not necessarily equate
with direct regulation of nearby genes. New strategies are there-
fore required to identify the subsets of binding events that are
central to regulatory network function.
Hematopoiesis has long served as a model process for
studying stem cells (Orkin and Zon, 2008). One of the earliest
branch points during hematopoietic differentiation is the specifi-
cation of the megakaryocyte (MK)/erythroid progenitor (MEP)
(Adolfsson et al., 2005). Subsequent formation of immature
MKs leads to the production of large numbers of anucleate plate-
lets. As the secondmost abundant cell in the blood, their primary
role is to maintain hemostasis and instigate wound healing on
vascular damage.
Being derived from a common precursor, the MK and erythro-
cyte lineages share a number of TFs critical for their develop-
ment, including GATA1, FOG1, SCL, and GFI1b. Other factors,
like EKLF (erythroid) and GABPa, FLI1, and RUNX1 (megakaryo-
cytic) have been implicated in the bifurcation of these lineages.
Analysis of cell-type specific regulatory elements is consistent
with the notion that combinations of these TFs constitute
lineage-specific regulatory codes. For example, sites for
GATA1 and SCL are found in several erythroid specific
enhancers (Anderson et al., 1998; Wadman et al., 1997) and
several enhancers active in MKs contain GATA and ETS binding
sites (Minami et al., 1998; Yamaguchi et al., 1998).
We have recently reported genome-wide combinatorial inter-
actions for ten key regulators of hematopoietic stem/progenitor
cells in the multipotent mouse hematopoietic progenitor cell
line 7 (HPC-7) (Wilson et al., 2010a), which revealed combinato-
rial interactions between a heptad of TFs (Scl, Lyl1, Lmo2, Gata2,
Runx1, Erg, Fli1). Subsequent in vivo validation confirmed a
previously unrecognized synergism between the three central
regulators of blood stem cell development Scl, Gata2, and
Runx1. Another elegant study examined the dynamic binding
and long-distance regulation by multi-TF complexes during
erythroid maturation using a mouse erythroleukemia cell line
model (Soler et al., 2010). Furthermore, recent studies have
extended genome-wide analysis of key hematopoietic transcrip-
tion factors to human leukemia cell lines (Fujiwara et al., 2009;
Pencovich et al., 2011). However, all the above studies were per-
formed in transformed cell lines. Any findings therefore come
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with the many caveats associated with the unphysiological
nature of immortalized cells. Here we report the genome-wide
binding of five key hematopoietic regulators in primary human
MKs. Knockdown in zebrafish of eight genes, regulated by all
five TFs and with no known function in hematopoiesis, showed
all to be essential for thrombocyte and/or erythroid develop-
ment, suggesting that multifactor chromatin immunoprecipita-
Figure 1. GATA2, RUNX1, FLI1, and SCL
Bind to the RUNX1 +23 and GATA1 to the
SCL +40 Enhancer in Primary Megakaryo-
cyte Cultures
(A) Cord blood CD34+ hematopoietic progenitor
cells were differentiated into CD41+ MKs using
a 10 day culture in serum-free medium containing
TPO and IL-1b. Subsequently ChIP for GATA1,
GATA2, RUNX1, FLI1, and SCL was performed.
(B) After culture, 71%–93%of cells were CD41+ as
determined by flow cytometry (IgG is depicted in
gray and CD41 stain in black). A cytospin and
modified Wright’s stain revealed the presence of
pro-MKs with nuclear separation in between
megakaryoblasts.
(C) ChIP material was validated by real-time PCR
using primer pairs for regions known to be bound
(positive region) or not bound (negative region).
For GATA2, RUNX1, FLI1, and SCL, the RUNX1
intron 1 +23 enhancer was used as a positive
region with the RUNX1 +31kb as corresponding
negative region. For GATA1, the SCL +40
enhancer was used as a positive region with the
SCL 16 as negative region (mean + SD; see
Supplemental Experimental Procedures for
details).
tion sequencing (ChIP-Seq) combined
with high-throughput zebrafish screening
is a widely applicable strategy to identify
regulators of complex mammalian devel-
opmental processes.
RESULTS
Genome-Wide Analysis of GATA1,
GATA2, RUNX1, FLI1, and SCL
Binding in Primary Human
Megakaryocytes
To determine genome-wide TF binding,
primary MKs were cultured from cord
blood CD34+ hematopoietic progenitor
cells (HPCs; R98% pure) for 10 days in
the presence of thrombopoietin and inter-
leukin-1b (Figure 1A). 3.3 million CD34+
cells produced a total of 94.7 million
primary cells, sufficient for comprehensive
genome-wideanalysis.After culture, 71%–
93% of cells expressed CD41 (Figure 1B)
and 20%–56% expressed the more
mature marker CD42a (data not shown).
Cytospin and modified Wright’s stain
demonstrated that most cells were at the
megakaryoblast stage, however, some pro-MKs with nuclear
separation were also seen (Figure 1B). Greater than 90% of cells
tested negative for CD34 expression and few cells expressed
markers of other lineages (CD11c, 0.4%–4.1%; CD14, 2.4%–
2.7%; CD15, 0.7%–2.3%; CD66a, 0.5%–1%; data not shown).
ChIP-Seq technology was then used to generate genome-
scale catalogs of sequences bound by GATA1, GATA2, RUNX1,
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FLI1, and SCL in primary human MKs. Before sequencing, ChIP
material was validated by quantitative polymerase chain reaction
(PCR). We have previously shown that the RUNX1 +23 enhancer
is bound by GATA2, RUNX1, FLI1, and SCL in mouse progenitor
cells (Wilson et al., 2010a), and the SCL +40 enhancer by GATA1
in erythroid cells (Ogilvy et al., 2007). As shown in Figure 1C,
significant binding of the relevant factors to these two regions
was also observed in primary human MKs.
The ChIP material was sequenced yielding between 10.3
million and 14.1 million mappable reads for each factor. Visuali-
zation of the raw data across the RUNX1 and TAL1 loci repro-
duced the PCR results with specific enrichment of the
RUNX1 +23 and SCL +40 regions (Figures 2A and 2B, respec-
tively). Inspection of several gene loci for MK-affiliated genes
showed that (1) the ITGA2B locus (coding for integrin aIIb, the
CD41 marker used to determine the purity of the MK cultures)
is bound by all five TFs (Figure 2C); (2) GP9 coding for the
MK-specific protein GPIX is bound by all but GATA2 (Figure 2D);
and (3)GP1BB is bound by all five TFs just like CD41 (Figure 2E).
Figure 2. GATA1, GATA2, RUNX1, FLI1, and
SCL Binding to the Human Megakaryocyte
Genome
(A–E) Raw ChIP-Seq read data was transformed
into density plots and displayed in the UCSC
genome browser above the tracks for gene
structure and vertebrate homology. The vertical
viewing range was set at 0–50. Black vertical bars
show the location of the PCR primers used to
validate the ChIPmaterial. Shown here are the loci
RUNX1 (A), SCL/TAL1 (B), ITGA2B (CD41) (C),
GP9 (CD42a) (D), and GP1BB (CD42c) (E).
(F) Each peak was allocated to be either within
a promoter, intragenic, or intergenic region. The
pie chart shows the distribution of the peaks
across those three categories (blue, green, and
red, respectively). See also Figure S1.
To comprehensively identify all binding
peaks across the genome, we generated
a control IgG ChIP sample to permit the
use of software tools specifically de-
signed to eliminate artifactual peaks
found in both test and control samples,
which allowed us to identify 4722 peaks
for GATA1, 2475 peaks for GATA2,
7345 peaks for RUNX1, 8688 peaks for
FLI1, and 3085 peaks for SCL (Figure 2F).
Over 33% of RUNX1 and FLI1 peaks
were situated in promoter regions,
whereas for GATA1, GATA2, and SCL
this did not exceed 14%.
Analysis of Combinatorial
Interactions Highlights a
Preference for All Five Factors
Binding Together
To obtain new insights into combinatorial
TF interactions, we next asked whether
the frequency of colocalization of spe-
cific combinations of TFs on the same target regions might
indicate preferential coregulatory activities. To this end, we
determined the number of overlapping peaks for all 26 possible
combinations involving binding of two ormore factors (Figure 3A,
left; see Tables S1 and S2 available online for all peak coordi-
nates and candidate target genes). To address statistical signif-
icance, we used a lower end estimate of 80,000 regions poten-
tially available for binding (Boyle et al., 2008; McDaniell et al.,
2010), determined the expected frequencies for all 26 binding
patterns and calculated significance of deviation between
observed and expected values (Figure 3A, right).The most
underrepresented pattern was binding by GATA1 and FLI1
without any other factor, suggesting that binding by GATA1
and FLI1 in the absence of larger multi-TF-complexes is not
favored. Interestingly, seven of eight combinations involving
GATA1 and SCL were overrepresented pointing to the impor-
tance of this pairing in megakaryopoiesis (Figure 3A). By far the
most significant combinatorial pattern was binding of all five
factors together suggesting an important role for this complex
Developmental Cell
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in MK transcriptional control. Of note, there was only a minor
overlap between the peaks identified here when compared to
those from a recently published study where four of the five
factors were analyzed in a mouse hematopoietic progenitor
cell line (Figure S1), suggesting that cell-type specific binding
previously reported for individual TFs (Heinz et al., 2010) extends
to multifactor combinatorial binding.
We next used sets of regions with particular TF occupancy
patterns for de novo motif discovery, which recovered the ex-
pected consensus binding motifs (Figure 3; see Figure S2 for
expected consensus motif sequences). For example, analysis
of sequences bound only by SCL andGATA1 recovered a typical
SCL/GATA1 composite binding motif (Figure 3Bi), also seen in
recent ChIP-Seq studies of Scl in erythroid cells (e.g., Kassouf
et al., 2010 and Soler et al., 2010) and now recognized as the
likely docking site for Scl/Gata complexes. This analysis also
recovered the SCL binding E-box motif (Figure 3Bii) as well as
a motif resembling an E-box, but not present in current collec-
tions of transcription factor consensus binding sites (Figure 3Biii).
Analysis of other subsets such as all regions bound by SCL and
GATA1 plus one or more of the other three factors recovered
additional expected motifs such as GATA, ETS, and RUNX
consensus sequences (e.g., Figures 3Biv–3Bvi), thus demon-
strating that expected motifs were present in the regions identi-
fied by ChIP-Seq analysis.
Only a Subset of Peak Occupancy Patterns Correlates
with Megakaryocyte-Specific Gene Expression
Having established the potential importance of combinatorial
interactions between GATA1, GATA2, RUNX1, FLI1, and SCL,
we next investigated the connectivity within the core network
formed by these five factors. As shown in Figure 4A, all five
TFs are characterized by a positive autoregulatory feedback
loop, and in addition contain extensive cross-regulatory links,
thus resulting in the formation of a densely connected core
circuit. Studies in lower model organisms have suggested that
regulatory networks commonly consists of densely connected
TF core circuits that control large numbers of tissue-specific
effector proteins (enzymes, structural proteins, etc.) (Davidson,
2010; Roy et al., 2010). With occupancy patterns being nonran-
domly distributed (Figure 3A), we next investigated the nature of
the candidate target genes for all possible 31 occupancy
patterns, and therefore mapped TF binding peaks to nearby
genes thus generating 31 target gene lists (Table S2). To identify
those sets of target genes most likely to be important for the
megakaryocyte phenotype, we next performed gene set enrich-
ment analysis (GSEA), which demonstrated that six occupancy
patterns were associated with genes highly enriched for MK-
specific expression (Figure 4B and Table S3). Of note, four of
these six peak occupancy patterns (P1, P2, P3, P5) had also
been found to occur much more frequently than expected by
chance (see Figure 3A). This convergence between statistical
analysis of peak pattern frequency and GSEA analysis of
neighboring genes therefore suggests that key aspects of the
megakaryocyte transcriptional program can be captured from
comprehensive analysis of our data set.
Of note, noneof the 31 gene lists showed significant correlation
withgenesspecifically repressed inMKs, thussuggesting that the
five-factor core circuit analyzed here largely functions as a posi-
tive regulator of MK expression. To further explore this notion,
we performed additional ChIP-Seq experiments to generate
genome-widemaps indicativeof active and repressedchromatin.
Trimethylation of histoneH3 lysine 4 (H3K4me3) was used tomap
active promoters, histone H3 acetylation (H3acet) for active
promoters as well as more distal elements, and trimethylation of
histone H3 lysine 27 (H3K27me3) as a mark for repressed chro-
matin. All three data sets displayed the expected patterns of
enrichment (Figure S3A). We therefore proceeded to categorize
all human promoters into three categories (inactive, bivalent and
active) basedon their patternof histonemodification (FigureS3B).
As expected, when gene expression in the three categories was
examined, the highest level of expression was found in the cate-
gory of ‘‘active’’ promoters (Figure S3C).Moreover, the fraction of
promoters bound by the five transcription factors was lowest for
the inactive promoters, at an intermediate level for bivalent
promoters and highest for the active promoters (Figure S3D).
Genome-wide analysis of chromatin status was therefore consis-
tent with the notion that the core TF circuit defined here is
predominantly involved in positive regulation of gene expression.
With analysis of combinatorial binding patterns, gene set
enrichment andchromatin analysis all converging onaconsistent
role for the GATA1/GATA2/RUNX1/FLI1/SCL core circuit within
Figure 3. Analysis of Combinatorial Binding Identifies Prevalent
Patterns and Suggests Indirect Recruitment of SCL and RUNX1
(A) The number of peaks for all 26 combinations involving binding of two or
more factors are shown on the left of the figure (red = bound, blue = not bound).
Z scores on the right indicate significance of deviation between observed and
expected instances for all 26 binding patterns. Seven of eight combinations
containing GATA1 and SCL were overrepresented (marked with a yellow star).
(B) De novo motif discovery on sequences bound only by GATA1 and SCL
recovers a typical SCL/GATA1 composite binding motif (i), the SCL binding
E-box motif (ii), and a motif resembling an E-box (iii). All regions bound by
GATA1 and SCL plus one or more of the other factors, recovered GATA, ETS,
and RUNX consensus sequences (iv, v, and vi, respectively). See also
Tables S1 and S2 and Figure S2.
Developmental Cell
Identification of Hematopoietic Regulators
600 Developmental Cell 20, 597–609, May 17, 2011 ª2011 Elsevier Inc.
wider MK transcriptional programs, we next developed a regula-
tory network model (Lin et al., 2010) illustrating the connectivity
of all genes controlled by TF peaks correlating with MK-specific
expression (e.g., the gene sets corresponding to patterns P1 to
P6 from Figure 4B). As illustrated in Figure 4C, target genes
controlled by the six different types of peaks are largely nonover-
lapping. This analysis therefore suggests that control of MK
effector genes mainly occurs via a single regulatory element
whereby several distinct combinations of GATA1/GATA2/
RUNX1/FLI1/SCL can be involved in contributing to MK-specific
Figure 4. A Regulatory Network Model for Megakaryocyte-Specific Expression
(A) GATA1, GATA2, RUNX1, FLI1, and SCL form a densely connected core circuit replete with positive feedback loops.
(B) Gene set enrichment analysis (GSEA) shows highly significant enrichment for expression in MKs in 6 of the 31 possible combinatorial binding patterns (see
Table S3 for full results). Shown are plots of the running sum for the genes regulated by these six patterns in relation to all genes ranked for expression in MKs
compared to six other human blood cell types (Watkins et al., 2009) (CD4, CD8, CD14, CD19, CD56, CD66b, and erythroblasts). The six occupancy patterns
significant in GSEA are labeled P1 to P6 for ease of representation in (C). The normalized enrichment score and false discovery rate q value are also shown.
(C) A regulatory network model for gene expression in MKs regulated by the six occupancy patterns showing significant correlation by GSEA. Shown are the links
to downstream target genes based on peak-to-gene mapping for the patterns P1–P6 (B). Although some genes are regulated by multiple patterns, most
downstream effector genes are controlled by a single node. See also Table S3 and Figure S3.
Developmental Cell
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expression. Taken together, comprehensive bioinformatic anal-
ysis has allowed us to generate a regulatory network model for
megakaryocyte-specific expression with a densely connected
core circuit controlling several hundred effector genes through
a relatively shallow hierarchy, a network architecture recently
predicted to be common for tissue-specific gene expression
programs (Davidson, 2010). It is important to note, however,
that not unexpectedly, the current five-factor network model
does not capture MK-specific expression in its entirety. Of the
top 200 megakaryocyte-specific genes, 67 form part of the
current network model, thus suggesting that alternative TF
combinations mediating MK-specific expression remain to be
discovered.
In Vivo Validation of Candidate Target Genes in
Zebrafish Identifies Eight Hematopoietic Regulators
With all five factors binding together being the most significant
combinatorial pattern in our data set (Figure 3A) and the most
highly enriched for MK-specific genes (Figure 4B and Table S3),
we hypothesized that concurrent binding by these five factors
represented an important control mechanism for hematopoietic
development. To explore this hypothesis further, we used the
genomic regions enrichment of annotations tool (GREAT)
(McLean et al., 2010), which defines genomic neighborhoods
for TF-bound peaks by attaching weights to flanking genes
based on their distance to the peak. Weighted gene lists are
then used to identify overrepresented biological functions.
GREAT analysis for the 144 regions bound by all five TFs showed
strong enrichment for a number of phenotypes, all of which were
hematopoietic and included decreased platelet count (Table 1).
Taken together therefore, concurrent binding of GATA1,
GATA2, RUNX1, FLI1, and SCL highlights a set of genes highly
enriched for known (and potentially unidentified) regulators of
hematopoiesis in general and of megakaryopoiesis more
specifically.
To further explore the biological significance of the subset of
genes bound by all five TFs, we performed functional studies
using zebrafish as a model for high-throughput in vivo validation.
Mapping peaks to genes identified 151 candidate target genes
for the 144 regions bound by all five TFs of which 24 (16%)
have a role in transcriptional control and 28 (19%) are involved
in signal transduction (Table S4). Fifty-seven of the 151 genes
were (1) expressed in MKs based on a recent compendium of
gene expression profiles in primary human hematopoietic cell
types (Watkins et al., 2009) and (2) displayed increased expres-
sion in a recently published MK differentiation time series data
set (Fuhrken et al., 2008). Eighteen of these 57 genes had known
hematopoietic functions, and of the remaining 39 genes, zebra-
fish orthologs could be readily identified for 37 genes. Morpho-
lino antisense oligonucleotides (MOs) were designed against
eight of these genes, chosen randomly to provide an unbiased
sampling, as well as against the TF nfatc1. Nfact1 was included
because even though NFATC1 had been implicated in transcrip-
tional control in lymphocytes (Shaw et al., 1988), there were no
prior data suggesting possible functions in megakaryopoiesis
(see Table S5 for a summary of selected genes). MOs targeting
these nine genes were injected into one-cell stage zebrafish
embryos and assayed for their effect on two hematological traits:
number of erythrocytes and number of thrombocytes. Remark-
ably, for all genes except nfatc1, injection of MOs caused a sig-
nificant reduction in the number of circulating blood cells at 48 hr
postfertilization (hpf) (Figure 5A) as confirmed by o-dianisidine
staining for hemoglobin production. Whereas emilin1 and sufu
MOs had a mild effect on erythropoiesis, ncor2, march2, smox,
pttg1Ip, max, and pdzk1ip1l MO injected embryos showed a
profound reduction in the number of mature erythrocytes.
To further explore potential hematopoietic functions for the
nine candidate genes, we examined cd41 expression at 72 hpf
in the caudal hematopoietic tissue (CHT) of MO injected fish
using the Tg(cd41:EGFP) transgenic line (Lin et al., 2005) (Figures
5B and 5C; for pictures and cell counts in multiple embryos, see
Table S6 and Figure S4). The CHT is widely recognized as the
anatomic site of definitive hematopoiesis in zebrafish embryos,
and cd41low and cd41high are considered to be the markers of
hematopoietic stem cells (HSCs) and thrombocytes, respec-
tively. For six genes (march2, max, smox, pttg1lp, emilin1, and
sufu) MO depletion resulted in a severe decrease in the number
of thrombocytes and HSCs. Ncor2 depletion resulted in a mild
phenotype. Pdzk1ip1l and nfatc1 MO injected embryos showed
no change in the number of cd41 positive cells when compared
to control embryos. Taken together, in vivo functional validation
therefore demonstrated that genes adjacent to DNA sequences
concurrently bound by GATA1, GATA2, RUNX1, FLI1, and SCL
Table 1. GREAT Analysis Shows Highly Significant
Overrepresentation of Hematopoietic Phenotypes and MK Gene
Expression Patterns for the Regions Bound by All Five TFs
Enriched Term Raw p value FDR q value
Abnormal hematopoietic system
physiology
3.5 E-07 2.0 E-03
Hematopoietic system phenotype 6.8 E-07 2.0 E-03
Anemia 1.5 E-06 2.9 E-03
Abnormal hematopoietic system/
development
2.1 E-06 3.0 E-03
Abnormal hematopoiesis 3.5 E-06 4.0 E-03
Anemia 4.4 E-06 4.2 E-03
Abnormal blood cell morphology/
development
6.6 E-06 5.5 E-03
Abnormal immune system morphology 1.2 E-06 8.6 E-03
Abnormal leukocyte cell number 2.8 E-05 1.5 E-02
Abnormal leukocyte morphology 4.3 E-05 2.1 E-02
Abnormal immune system cell
morphology
5.1 E-05 2.1 E-02
Abnormal mononuclear leukocyte
cell morphology
7.2 E-05 2.8 E-02
Decreased platelet cell number 1.6 E-04 4.6 E-02
MsigDB gene sets perturbation
Genes upregulated in AML
samples of the FAB class M7
3.1 E-06 2.8 E-03
Genes essential to the development
of megakaryocytes, as expressed
in normal cells and essential
thrombocythemic cells
1.0 E-05 4.6 E-03
FDR, false discovery rate; GREAT, genomic regions enrichment of anno-
tations tool; TFs, transcription factors.
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are highly enriched for previously unknown hematopoietic
regulators.
PDZK1IP1 Shares Transcriptional Enhancer
Elements with the Essential Hematopoietic
Stem Cell Regulator SCL
Identification of a hematopoietic function in zebrafish for
pdzk1ip1I was of particular interest because (1) its mammalian
ortholog PDZK1IP1 (also known as MAP17) encodes a mem-
brane associated protein shown to modulate the levels of reac-
tive oxygen species (Guijarro et al., 2007) that have recently
emerged as important determinants of blood stem cell function
(Tothova et al., 2007); (2) PDZK1IP1 is situated immediately 30
of the hematopoietic master regulator SCL (see Figure 6A); (3)
this arrangement is conserved between mammals and zebrafish
(Gottgens et al., 2002a); and (4) an erythroid enhancer regulating
murine Scl expression is located 30 of PDZK1IP1 (+40 element;
Figure 6A) (Delabesse et al., 2005). We previously argued that
this Scl 30 enhancer was the cause for close linkage between
Scl and Pdzk1ip1 during evolution because major rearrange-
ments would have interfered with SCL expression (Ogilvy et al.,
2007). However, the identification of a hematopoietic function
for pdzk1ip1l suggests that the intimate linkage of SCL and
PDZK1IP1 might be due to the fact they share regulatory
elements to mediate their respective functions in hematopoietic
cells. Interestingly, PDZK1IP1 is upregulated during megakaryo-
cyte differentiation from CD34+ HPCs (Fuhrken et al., 2008) and
we have previously observed that the Scl +19 enhancer targets
expression to megakaryocytes (Silberstein et al., 2005).
To investigate the possibility of coregulation, we first deter-
mined expression of Pdzk1ip1 in mouse embryos. As shown in
Figure 6B, Pdzk1ip1 was expressed in the midgestation mouse
embryo both in the dorsal aorta (AGM region) and fetal liver in
the hematopoietic domains that also express Scl. Of note,
expression in dorsal aorta endothelium and hematopoietic clus-
ters as well as a subset of fetal liver cells was highly reminiscent
of the expression pattern previously seen in transgenic mouse
embryos with the +19 enhancer fused to an Scl-promoter-lacZ
reporter gene (Sanchez et al., 1999).
To examine hematopoietic expression of Pdzk1ip1 further, we
generated embryonic stem cells (ESCs) with a lacZ reporter gene
knocked into the ATG start codon of Pdzk1ip1 (Figures 6C, S5A,
Figure 5. In Vivo Morpholino Screen in Zebrafish Identifies Eight Regulators of Hematopoiesis
(A) MOs were injected into one-cell stage embryos and number of erythrocytes assessed with o-dianisidine staining. For eight genes, injection of MOs resulted in
a reduced number of blood cells in circulation at 48 hr postfertilization (hpf). For clarity representative images illustrating three different phenotypes (unaffected
[left], mild [middle], and severe [right]) are shown with the number of embryos in each group indicated in the lower, left corner. The number in the upper left corner
of the very left image shows the total number of embryos used in each experiment. The predominant phenotype is framed in red. Black arrow indicates
hemoglobin staining in the control.
(B) Wild-type zebrafish embryo at 72 hpf. Confocal images presented in (C) were taken of the caudal hematopoietic tissue, indicated by the boxed region.
(C) MOs were injected into the one-cell stage transgenic Tg(cd41:EGFP) zebrafish embryos and assayed for their effect on the number of presumed hemato-
poietic stem cells (cd41low) and thrombocytes (cd41high; white arrows) at 72 hpf. Formarch2 (n = 44),max (n = 63), smox (n = 60), pttg1lp (n = 50), emilin1 (n = 65),
and sufu (n = 65), a severe decrease of cd41 positive cells was observed. Ncor2 (n = 53) depletion resulted in a mild phenotype, and pdzk1ip1l (n = 49) and nfatc1
(n = 60) MO injected embryos showed no phenotype. See also Tables S4–S7 and Figure S4.
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Figure 6. PDZK1IP1 Shares Transcriptional Enhancer Elements with the Hematopoietic Master Regulator SCL
(A) ChIP-Seq results (as for Figure 2) across the human SCL/PDZK1IP1 gene locus with the location of the +19 and +40 enhancer elements indicated
by arrowheads.
(B) Pdzk1ip1 is expressed in the fetal liver (FL) and dorsal aorta (DA) region of midgestation mouse embryos. Shown are the results from in situ hybridization
experiments using transverse sections of day 12.5 mouse embryos with a magnified view of the dorsal aorta on the right hand side.
(C) Targeting of a lacZ reporter gene into the 50UTR of mouse Pdzk1ip1 in ESCs. The neo selection marker was flanked by loxP sites and removed using
Cre-mediated recombination.
(D) Pdzk1ip1 lacZ knockin ESCs express lacZ after differentiation into embryoid bodies. The top section shows day 6 embryoid bodies stained for lacZ using the
chromogenic substrate X-Gal with wild-type (wt) cells on the left and Pdzk1ip1 knockin cells (ki) on the right. The bottom part shows flow cytometry analysis using
the fluorogenic lacZ substrate FDG with approximately 25% of Pdzk1ip1 knockin cells expressing the lacZ reporter (FDG, x axis; Side Scatter SSC, y axis).
(E) Hematopoietic colony forming activity is confined to Pdzk1ip1 expressing cells in ESC differentiation assays. Pdzk1ip1 expressing cells were purified by flow
cytometry and analyzed for colony forming ability. Shown from left to right are colony numbers per 100,000 cells for primitive erythroid (EryP), definitive erythroid
(EryD), mixed lineage (Mixed), and macrophage colonies (MP) (mean + SD).
(F) The +19 enhancer drives expression to the fetal liver in transgenic mice when fused to the Pdzk1ip1 promoter. Shown on the left is a representative E12.5
transgenic embryo carrying the Pdzk1ip1 promoter fused to the lacZ reporter gene with no observable staining. Shown on the right is a representative transgenic
embryo for the Pdzk1ip1 promoter fused to the +19 enhancer with readily identifiable staining in the fetal liver (arrowhead). See also Figure S5.
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and S5B) and then used lacZ expression during ESC differentia-
tion as a surrogate for Pdzk1ip1 expression. ESCs were differen-
tiated into embryoid bodies to produce hematopoietic cells
that could be analyzed by flow cytometry and colony assays.
At day 6 of differentiation, 25% of embryoid body cells derived
from Pdzk1ip1 knockin (KI) ESCs displayed lacZ staining (Fig-
ure 6D) with the vast majority of hematopoietic colony forming
activity found in the lacZ expressing cells (Figure 6E). Pdzk1ip1
expression therefore marks hematopoietic cells in both mouse
embryos and differentiating ESCs within the known expression
domain of Scl.
To investigate whether the regulatory elements previously
shown to drive Scl expression can also act on the Pdzk1ip1
promoter, we generated transgenic mouse embryos carrying
the Pdzk1ip1 promoter with and without the Scl +19 enhancer
fused to a lacZ reporter gene. Of 15 transgenic embryos with
the Pdzk1ip1 promoter alone, only two showed expression (in
the brain and limb buds, respectively). By contrast, 7 of 15 trans-
genic embryos for the promoter/enhancer construct showed
staining, with five of seven embryos displaying strong staining
in the fetal liver (Figure 6F) in a pattern highly reminiscent to
whatwe observed previously for the +19 enhancer in conjunction
with the Scl promoter (Sanchez et al., 1999). Of note, histological
analysis demonstrated that LacZ expressing cells included fetal
liver megakaryocytes (Figure S5C). These results demonstrate
that a regulatory element previously thought to simply control
expression of Scl can act in vivo to mediate expression from
the Pdzk1ip1 promoter. However, the Scl +19 enhancer was
previously shown to interact with both Scl as well as heterolo-
gous promoters (Sanchez et al., 1999). The experiments pre-
sented here therefore do not directly prove that the +19 enhancer
normally mediates specific Pdzk1ip1 regulation in vivo. Our
results are nevertheless suggestive of a model whereby two
very different proteins aremaintained in close linkage throughout
vertebrate evolution because they share key regulatory elements
to sustain their expression in hematopoietic cells where they
both perform important functions. Similar coregulatory relation-
ships may be common throughout the genome, and thus an
important consideration to be taken into account when utilizing
ChIP-Seq studies for the reconstruction of regulatory networks.
DISCUSSION
Detailed molecular studies have shown individual TFs to play
critical roles at various stages of MK maturation. For example,
a hypomorph mouse model of Gata1 displays reduced platelet
numbers associated with deregulated MK proliferation and
severely impaired cytoplasmic maturation (Shivdasani et al.,
1997). The other TFs investigated in this study, GATA2,
RUNX1, FLI1, and SCL, have also been previously shown to
play important roles in MK differentiation (Growney et al., 2005;
Hart et al., 2000; Huang et al., 2009b; Ichikawa et al., 2004; Mik-
kola et al., 2003; Song et al., 1999; Spyropoulos et al., 2000). Of
note, these four factors also represent key players in regulatory
network circuits operating in HSPCs (Gottgens et al., 2002b;
Landry et al., 2009; Pimanda et al., 2007) consistent with the
previously suggested notion of significant overlap between tran-
scriptional control mechanisms in MKs and HSPCs (Huang and
Cantor, 2009).
The five-factor ChIP-Seq data set generated made it feasible
for us to perform a global analysis of combinatorial transcrip-
tional control in a human primary myeloid cell type. Previous
studies, which only examined individual promoter fragments,
had revealed transcriptional cooperativity in MKs between
RUNX1 and GATA1 (Elagib et al., 2003; Xu et al., 2006) as well
as between FLI1 and GATA1 (Huang et al., 2009a). The latter
was somewhat surprising given the well characterized antago-
nism between GATA1 and ETS family TFs during erythroid
differentiation. Our genome-wide data sets support frequent
co-occupancy of GATA1 and FLI1 in MK cells with a total of
1335 regions bound simultaneously by both factors. However,
the vast majority (1094) of these are bound by additional factors
and binding of GATA1 and FLI1 without any of the other factors
was in fact the most underrepresented occupancy pattern.
These observations suggest that activatory interactions between
GATA1 and FLI1 may at least in part be mediated through the
assembly of larger multiprotein complexes. Of particular rele-
vance may be the observation that >700 regions are bound by
GATA1 and FLI1 together with RUNX1. RUNX1 has been shown
previously to interact at the protein level with both GATA1 and
FLI1 (Huang et al., 2009a; Elagib et al., 2003). Moreover,
RUNX1 expression ismaintained inMKswhereas it is downregu-
lated during erythroid differentiation (Elagib et al., 2003). Our
combinatorial binding data are therefore consistent with a model
where additional factors such as RUNX1 mediate transcriptional
cooperation between GATA1 and FLI1 in MKs whereas antago-
nistic interactions may prevail in their absence as previously
reported for the erythroid lineage.
Genes next to regions bound by all five factors were highly
enriched for known regulators of MK differentiation and/or func-
tion. This observation prompted us to investigate the possibility
that genes of unknown hematopoietic function with binding
peaks for all five factors may also be enriched for the same
functional categories. To provide biological insight, genome-
scale hypothesis-generating screens such as ChIP-Seq
experiments need to be coupled with meaningful assays for
downstream functional validation. Here we took advantage of
the zebrafish model because hematopoietic control mecha-
nisms are highly conserved between zebrafish and human/
mouse, yet only the zebrafish allows relatively high-throughput
knockdown analysis in vivo in the context of a whole animal.
Coupling the multifactor ChIP-Seq screen with zebrafish
in vivo validation allowed us to identify eight regulators of throm-
bopoiesis and/or erythropoiesis. Of note, none of the MOs
caused a lack of blood circulation and at the concentration
used, with the exception of two (smox and max), MO knock-
down did not affect wider aspects of morphology, underscoring
the hematopoietic specificity of the uncovered phenotypes.
Given that seven MOs affected both erythrocytes and thrombo-
cytes, it is possible that at least some of those genes may oper-
ate at the level of immature progenitors or blood stem cells.
Given the overlap of key transcriptional regulators in MKs and
HSCs, potential functions in blood stem cells might perhaps
not be too surprising but will require further fine dissection of
knockdown phenotypes.
Recent ChIP-Seq studies of individual transcription factors in
two different hematopoietic lineages suggested that binding
patterns are largely lineage-specific (Heinz et al., 2010) with
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shared peaks in one study of Scl being as low as 6% (Palii et al.,
2011). Comparison of the megakaryocyte data generated here
with a recently published hematopoietic progenitor data set (Wil-
son et al., 2010a) confirmed the predominance of lineage-
specific binding patterns, and in addition demonstrated that
regions bound by multiple factors are also largely lineage-
specific. This suggests that additional lineage-specific transcrip-
tion factors may play a part in controlling cell-type specific
accessibility of regulatory regions through interactions with
chromatin modifying enzymes. The likely relevance of additional
MK-specific transcription factors is further emphasized by our
observation that the five factors studied here may only account
for 30% of MK-specific expression. Additional important players
within MK transcriptional programs are likely to include NF-E2,
MEIS1, and E2A (Shivdasani, 1996; Hisa et al., 2004; Semerad
et al., 2009). Our demonstration that PDZK1IP1 shares transcrip-
tional regulatory elements with the blood stem cell regulator SCL
has implications reaching beyond a better understanding of this
particular gene locus. The notion that a given regulatory region
can control multiple genes is well established, but past experi-
mental analysis has largely focused on clusters of related genes
such as the b-globin locus (Tolhuis et al., 2002) or tandem arrays
of interleukin genes (Loots et al., 2000). Coregulation within these
gene loci is likely to have arisen in parallel with local gene dupli-
cation events resulting in coordinated control of evolutionary and
functionally related genes. By contrast, SCL and PDZK1IP1
encode unrelated proteins and it is likely that their original juxta-
position within vertebrate genomes was accidental. Our identifi-
cation of PDZK1IP1 as a hematopoietic regulator together with
the demonstration that SCL and PDZK1IP1 share transcriptional
enhancer elements provides a rationale for the tight linkage
between these two genes throughout vertebrate evolution.
Moreover, our data illustrate the potential pitfalls of mapping
transcription factor binding events to a single target gene when
reconstructing regulatory networks. The +19 enhancer is
approximately equidistant to the SCL and PDZK1IP1 promoters
and evidently can control both. Transgenic in vivo analysis as
performed here will be too time consuming and costly for global
mapping of regulatory interactions between distal enhancers
and the promoters of neighboring genes. However, further
reductions in DNA sequencing costs may mean that chro-
matin-capture based methods providing a genome-wide view
of promoter/enhancer interactions (Fullwood et al., 2009) will
eventually perform this integral part of regulatory network
reconstruction.
Previous multi-TF ChIP-Seq studies have revealed layers of
information that can only be obtained from integrated analysis
of multiple factors. For example, computational analysis of a
12-factor ChIP-Seq data set from mouse ESCs suggested that
genome-scale analysis of combinatorial TF occupancy has the
potential to predict absolute and differential gene expression
(Ouyang et al., 2009). A five-factor ChIP-Seq study in an
erythroid model cell line revealed that multi-TF complex binding
oftenmarks sites of long-range genomic interactions (Soler et al.,
2010). Here we have shown that multifactor ChIP-Seq surveys
coupled to high-throughput in vivo functional screening provide
a powerful strategy toward isolating key regulators of cellular
phenotypes. Future detailed functional analyses of the eight
hematopoietic regulators identified here, has the potential to
integrate new regulatory pathways into an emerging framework
of blood development.
EXPERIMENTAL PROCEDURES
Megakaryocyte Culture
Cord bloodwas obtained after informed consent under a protocol approved by
the National Research Ethics Service. CD34-positive cells (R98%) isolated
by magnetic cell sorting (Myltenyi Biotec), were seeded at 1 3 105 cells/ml
in CellGro SCGM medium (CellGenix) with 100 ng/ml human TPO (CellGenix)
and 10 ng/ml IL-1b (Miltenyi Biotec) and incubated for 10 days. Flow cytometry
was performed on a CyAn ADP 9 color (Beckman Coulter) as described
(Macaulay et al., 2007) using the following antibodies: CD11cPE-Cy5 or V450
(clone B-ly6; Becton Dickinson [BD]), CD14PB (clone M5E2; BD), CD15APC
(clone HI98; BD) or V450 (clone MMA; BD), CD34PE (clone 581; Beckman
Coulter), CD41APC (clone HIP8; BD), CD42aF (clone ALMA.16; BD), CD66PE
(clone B6.2; BD), and IgGAPC (clone MOPC-21; BD).
Chromatin Immunoprecipitation
ChIP assays were performed as previously described (Forsberg et al., 2000)
with 9.4–12.6 3 106 cells and anti-GATA1 (ab11963, Abcam), anti-GATA2
(clone H-116, Santa Cruz), anti-RUNX1 (ab23980, Abcam), anti-FLI1
(ab15289, Abcam), anti-TAL1 antibody (clone C-21, Santa Cruz) and nonspe-
cific Rabbit IgG (I5006; Sigma Aldrich). Samples were sequenced using the
Illumina GII Genome Analyzer. Sequence data have been submitted to
http://www.ncbi.nlm.nih.gov/geo (GEO record GSE24674).
ChIP-Seq Analysis
Three peak finding programs (Peakseq [Rozowsky et al., 2009], Findpeaks
[Fejes et al., 2008] and model-based analysis of ChIP-Seq [MACS] [Zhang
et al., 2008]) were used, based on previous observations that there is no single
algorithm of choice when calling peak regions for different TFs (Laajala et al.,
2009). De novomotif discovery was performed usingMEME (Bailey and Elkan,
1994) or bioprospector (Liu et al., 2001) and motifs were compared with the
JASPAR_CORE database (Bryne et al., 2008). Matches to consensus
sequences were determined as described using TFBSSearch (Chapman
et al., 2004). Peaks in promoters and introns were allocated to that gene and
the remainder of peaks to the nearest 30 and 50 genes in a 100 kb region. Inter-
sects of gene lists were generated using Galaxy (Goecks et al., 2010), gene
ontology terms were analyzed using GO Term Mapper (Lewis-Sigler Institute
for Integrative Genomics at Princeton University), and gene set enrichment
analysis was performed using the GSEA software (Subramanian et al., 2005).
Zebrafish Knockdown
General maintenance, collection, and staging were carried out according to
the Zebrafish Book (Westerfield, 1994). Antisense MOs (Gene Tools) were de-
signed complementary to the 50 sequence near the start of translation (max
and sufu), or at splice junctions (ncor2, march2, smox, nfatc1, pttg1lp, emilin1,
and pdzk1ip1l) (Table S7). An aliquot of 0.8 nl morpholino-containing solution
was injected in zebrafish embryos at the one- to two-cell stage. For march2
and pdzk1ip1l a MO concentration of 3 mg/ml and for ncor2, smox, nfatc1,
pttg1lp, max, emilin1, and sufu a MO concentration of 6 mg/ml was used.
Efficiency of splice-site MOs was determined by RT-PCR (Table S7). Total
RNA was isolated from control and splice MO injected embryos using the
RNeasyMini Kit (QIAGEN) and cDNA synthesized using SuperScript III (Invitro-
gen). Staining of hemoglobin by o-dianisidine was performed as described
(Detrich et al., 1995). Photomicrographs were taken with a Zeiss camera
AxioCam HRC attached to a LeicaMZ16 FA dissecting microscope (Leica
Microsystems).
Pdzk1ip1 KI Mouse ESCs
To generate Pdzk1ip1 KI ESCs a targeting vector was generated by bacterial
recombineering (Liu et al., 2003) where 131bp of exon 1 of Pdzk1ip1 (contain-
ing the ATG site) were substituted by a LacZ reporter gene and a LoxP-PGK-
Neo-LoxP cassette. Targeting was determined by Southern blot using 50 and 30
probes outside the targeting vector. Targeted cells were transiently trans-
fected with PGK-Cre for deletion of the Neo cassette (Figure S5). Pdzk1ip1
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KI ESwere differentiated into embryoid bodies as described (Keller et al., 1993)
and stained with X-gal as described (Smith et al., 2008). For sorting, embryoid
bodies were disrupted at day 6 of differentiation and stained with Fluorescein
di(b-D-galactopyranoside) (FDG) (Sanchez et al., 1999). Cells were plated in
methocult (Stem Cell Technologies) with appropriate cytokines (Peprotech,
R&D) and scored after 7 days.
Transgenic Mice and In Situ Hybridization
Pdzk1ip1-Pr/Lac and +19/Pdzk1ip1-Pr/Lac transgenic constructs were gener-
ated by inserting a 4.5 kb fragment containing the Pdzk1ip1 promoter and a
640 bp fragment containing the +19 enhancer into the pGLac vector. Methods
for transgenic mice generation and in situ hybridization are described else-
where (Wilson et al., 2010b).
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